TRLV (Trulieve Cannabis) Margin of Safety % (DCF Earnings Based): N/A (As of Jun. 25, 2026)


TRLV Trulieve Cannabis Corp TRLV
63 GF Score
Price $8.50
GF Value $6.03
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Trulieve Cannabis Margin of Safety % (DCF Earnings Based)?

Margin of Safety % (DCF Earnings Based) = (Intrinsic Value: DCF (Earnings Based) - Current Price) / Intrinsic Value: DCF (Earnings Based).

Note: Discounted Earnings model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

Trulieve Cannabis's Predictability Rank is Not Rated. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF Earnings Based) is not calculated.

TRLV vs ZTS: Margin of Safety % (DCF Earnings Based) Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Trulieve Cannabis's Margin of Safety % (DCF Earnings Based), along with its competitors' market caps and Margin of Safety % (DCF Earnings Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Trulieve Cannabis Margin of Safety % (DCF Earnings Based) vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Trulieve Cannabis's Margin of Safety % (DCF Earnings Based) distribution charts can be found below:

* The bar in red indicates where Trulieve Cannabis's Margin of Safety % (DCF Earnings Based) falls into.


TRLV
63GF Score
Trulieve Cannabis Corp TRLV
Margin of Safety % (DCF Earnings Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Trulieve Cannabis (TRLV) Overvalued in 2026?

Based on GuruFocus' analysis, Trulieve Cannabis stock appears to be overvalued. The current stock price of $8.50 is trading 41% above its estimated GF Value™ of $6.03. GuruFocus considers Trulieve Cannabis to be Significantly Overvalued.

Key valuation signals for TRLV:

  • Margin of Safety % (DCF Earnings Based): N/A
  • GF Value™: $6.03 vs. price of $8.50 (41% above fair value)
  • GF Score™: 63/100 with 6 warning signs

No single metric tells the full story. See the TRLV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Trulieve Cannabis Business Description

Other Exchanges T0A:GermanyTRUL:Canada
Address 3494 Martin Hurst Road, Tallahassee, FL, USA, 32312
Trulieve Cannabis Corp is a vertically integrated cannabis company that grows, produces, and sells cannabis products. It has licenses to operate in Arizona, Colorado, Connecticut, Florida, Georgia, Maryland, Ohio, Pennsylvania, and West Virginia, where it sells medical cannabis products. In addition, the company sells cannabis products for adult use in Arizona, Colorado, Connecticut, Maryland, and Ohio. The firm's operations are substantially located in Florida and, to a lesser extent, in Arizona and Pennsylvania.
63GF Score

Get the complete analysis for TRLV

Margin of Safety % (DCF Earnings Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$8.50
Price
$6.03
GF Value